statut_color,statut,statut_name,NCTId,eudraCT,CTIS,completion_year,clinical_trial_title,acronym,intervention_type
‚¨õ,4,4 : pas de r√©sultats post√©s ni publi√©s,NCT00370240,,,2008,Efficacy of Infiltration of Chlorhydrate of Ropivacaine in the Prevention of Chronic Breast Pain After Surgery for Breast Cancer.,,OTHER
‚¨õ,4,4 : pas de r√©sultats post√©s ni publi√©s,NCT00853710,,,2009,Validation of a Semiquantitative Screening Assay for PSA,,OTHER
üü•,3,3 : r√©sultats post√©s ou publi√©s apr√®s les 36 mois,NCT01455363,,,2011,"Etude perop√©ratoire de la Perfusion Sanguine Des Carcinomes Basocellulaires Par Imageur Laser Doppler, au Cours de la Manipulation de l'Influx art√©riel Tumoral - Recherche d'un ph√©nom√®ne d'hyper√©mie Tumorale Post-occlusive",HPOB,PROCEDURE
‚¨õ,4,4 : pas de r√©sultats post√©s ni publi√©s,NCT01448759,,,2012,Prospective Evaluation of Plasma Alcohol Concentration in Patients Receiving Paclitaxel or Docetaxel Infusion,ALCOOTAX,OTHER
‚¨õ,4,4 : pas de r√©sultats post√©s ni publi√©s,NCT01334008,,,2012,Development and Validation of a Circulating Tumor DNA Detection Technique in Patients With Metastatic Choroidal Melanoma,,BIOLOGICAL
‚¨õ,4,4 : pas de r√©sultats post√©s ni publi√©s,NCT02839473,,,2014,Hydrosorb¬Æ Versus Control (Water Based Spray) in the Management of Radio-induced Skin Toxicity: Multicentre Controlled Phase III Randomized Trial,HYDROSORB,DEVICE
üü•,3,3 : r√©sultats post√©s ou publi√©s apr√®s les 36 mois,NCT00957411,2008-001053-18,,2014,"Phase II Randomized Assessing Pelvic Irradiation Combined With Cisplatin Alone or Cisplatin Plus Cetuximab in Patients With Carcinoma of the Cervix Stage IB2, II and III",CETUXICOL,DRUG
‚¨õ,4,4 : pas de r√©sultats post√©s ni publi√©s,NCT02849106,,,2015,Predictive Response to Chemotherapy (FOLFOX or FOLFIRI) by ex Vivo Culture 3D Technique in Metastatic Colorectal Cancer: a Preliminary Study,CULTURE3D,PROCEDURE
‚¨õ,4,4 : pas de r√©sultats post√©s ni publi√©s,NCT01350908,,,2015,Development and Validation of a Circulating Tumor DNA Detection Technique in Patients With Ovarian Cancer,,OTHER
‚¨õ,4,4 : pas de r√©sultats post√©s ni publi√©s,NCT02519166,,,2015,,Biofilm Plaie,BIOLOGICAL
üü©,1,1 : r√©sultats post√©s ou publi√©s dans les 12 mois,NCT01349842,,,2018,CirCe01 Study: Evaluation of the Use of Circulating Tumour Cells to Guide Chemotherapy From the 3rd Line of Chemotherapy for Metastatic Breast Cancer,CirC√©01,OTHER
üü©,1,1 : r√©sultats post√©s ou publi√©s dans les 12 mois,NCT01373710,2009-017218-63,,2018,Phase 1-2 Study of Safety and Efficacy of Intrathecal Trastuzumab Administration in Metastatic HER2 Positive Breast Cancer Patients Developing Carcinomatous Meningitis,HIT,DRUG
‚¨õ,4,4 : pas de r√©sultats post√©s ni publi√©s,NCT02831634,,,2018,A Feasibility Study to Identify T-cell Responses to Neo-epitopes in Tumor Invaded Lymph Nodes,,PROCEDURE
üüß,2,2 : r√©sultats post√©s ou publi√©s entre 12 et 36 mois,NCT01956695,2012-003786-17,,2018,Phase II Study Evaluating the Efficacy of Lenalidomide in Association With Rituximab in Refractory or Relapse of Primary Central Nervous System Lymphoma (PCNSL),REVRI,DRUG
üü©,1,1 : r√©sultats post√©s ou publi√©s dans les 12 mois,NCT01975142,,,2019,Validity of HER2-amplified Circulating Tumor Cells to Select Metastatic Breast Cancer Considered HER2-negative for Trastuzumab-emtansine (T-DM1) Treatment.,,DRUG
üü©,1,1 : r√©sultats post√©s ou publi√©s dans les 12 mois,NCT02408393,,,2019,MIRs03: A Double-blind Randomized Trial of Paravertebral Block With Ropivacaine Before Breast Cancer Surgery: Effects on Chronic Postoperative Pain,MIRs03,DRUG
‚¨õ,4,4 : pas de r√©sultats post√©s ni publi√©s,NCT02875652,,,2019,Study of Circulating Tumoral DNA Evolution in Plasma in Choroidal Melanoma,ctDNA MU,BIOLOGICAL
üü©,1,1 : r√©sultats post√©s ou publi√©s dans les 12 mois,NCT02428842,,,2020,Biomarker Evaluation in Advanced Stage Cervical Cancer by an International Working Group. Tumor Stages (1B1 - 4),BIO-RAIDs,PROCEDURE
‚¨õ,4,4 : pas de r√©sultats post√©s ni publi√©s,NCT02834494,,,2020,"3D Elastography (Shear Wave) : Assessment of Response to Neo-adjuvant Chemotherapy (NACT) : in Vivo Quantification, for Patients With a Locally Advanced Breast Cancer.",NEO-ELASTO,PROCEDURE
‚¨õ,4,4 : pas de r√©sultats post√©s ni publi√©s,NCT03703557,,,2020,Feasibility Study on the Possibility of Isolation of Volatile Organic Compounds (VOCs) Related to the Olfactory Signature of Breast Cancer,KDOG2,DIAGNOSTIC_TEST
‚¨õ,4,4 : pas de r√©sultats post√©s ni publi√©s,NCT02849145,,,2020,Study to Evaluation Interest of the Circulating Tumor DNA Dosage in Patient With Hepatic Metastatic Uveal Melanoma Candidate to Complete Resection (R0),,BIOLOGICAL
üü©,1,1 : r√©sultats post√©s ou publi√©s dans les 12 mois,NCT01351870,,,2020,A Prospective Randomised Controlled Trial of Hyperfractionated Versus Conventionally Fractionated Radiotherapy in Standard Risk Medulloblastoma,SIOP-PNET-4,RADIATION
‚¨õ,4,4 : pas de r√©sultats post√©s ni publi√©s,NCT02843386,,,2020,Randomized Phase III Study Comparing an Adjuvant Chemotherapy With Fotemustin to Intensive Surveillance in Patients With High Risk Uveal Melanoma,FOTEADJ,OTHER
‚¨õ,4,4 : pas de r√©sultats post√©s ni publi√©s,NCT02608346,,,2021,Circulating Tumor DNA and Follow-up of BRCA1 Mutation Carriers (CirCa 01),,PROCEDURE
üü©,1,1 : r√©sultats post√©s ou publi√©s dans les 12 mois,NCT03109080,2016-001837-28,,2021,"A Phase I of Olaparib With Radiation Therapy in Patients With Inflammatory, Loco-regionally Advanced or Metastatic TNBC (Triple Negative Breast Cancer) or Patient With Operated TNBC With Residual Disease",RadioPARP,DRUG
‚¨õ,4,4 : pas de r√©sultats post√©s ni publi√©s,NCT02842723,,,2021,"Phase II Study on the Management of Pediatric Craniopharyngioma by a Combination of Partial Surgical Resection, and Protontherapy",,RADIATION
‚¨õ,4,4 : pas de r√©sultats post√©s ni publi√©s,NCT04541537,,,2021,Feasibility Study on the Possibility of Isolation of Volatile Organic Compounds (VOCs) Related to the Olfactory Signature of Breast Cancer,KDOGCOV,DIAGNOSTIC_TEST
‚¨õ,4,4 : pas de r√©sultats post√©s ni publi√©s,NCT02546453,,,2021,Use of Specific Genetic Alteration s of Tumoral Cells Identified by NGS to Follow Peripheral Samples of Children With Metastatic and/or High Risk Solid Tumor -,NGSKids,BIOLOGICAL
‚¨õ,4,4 : pas de r√©sultats post√©s ni publi√©s,NCT04369066,,,2022,"COVID-19 Study of the Serological Response Against the SARS-CoV-2 Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie and Institute Pasteur",Curie-O-SA,DIAGNOSTIC_TEST
‚¨õ,4,4 : pas de r√©sultats post√©s ni publi√©s,NCT04478175,,,2022,Prospective Evaluation of a Program for Early Identification of Needs and Multidisciplinary Intervention in Supportive Care in Digestive Oncology - DISSPO Parcours Dig' Study,DParcoursDig,OTHER
‚¨õ,4,4 : pas de r√©sultats post√©s ni publi√©s,NCT03298893,,,2022,A Phase-I Study of Nivolumab in Association With Radiotherapy and Cisplatin in Locally Advanced Cervical Cancers Followed by Adjuvant Nivolumab for up to 6 Months. NiCOL,NiCOL,DRUG
‚¨õ,4,4 : pas de r√©sultats post√©s ni publi√©s,NCT04327063,,,2022,A Double-blind Randomized Trial of Interpectoral Nerve Block (Pecs 1 and 2) With Ropivacaine Versus Placebo Before Breast Cancer Surgery: Effects on Acute Postoperative Pain. (MIRs 04),,DRUG
‚¨õ,4,4 : pas de r√©sultats post√©s ni publi√©s,NCT04145817,,,2022,"Clinical Application of the European Horizon 2020 Research Project ""BRIDGES"" - Study of the Psychological Impact of Breast Cancer Risk Communication in Cancer Genetics Based on the Personalized Estimation of the BOADICEA V5/PLUS Model",BRIDGEScohort2,GENETIC
‚¨õ,4,4 : pas de r√©sultats post√©s ni publi√©s,NCT03011528,,,2023,CombinaiR3 - First-line Treatment of Ewing Tumours With Primary Extrapulmonary Dissemination in Patients From 2 to 50 Years,CombinaiR3,PROCEDURE
‚¨õ,4,4 : pas de r√©sultats post√©s ni publi√©s,NCT02849158,,,2023,Interest in Studying Fibroblast Before and After Neoadjuvant Chemo-radiotherapy in Patient With Locally Advanced Rectal Adenocarcinoma : Exploratory Study,FibroRect,OTHER
üü©,1,1 : r√©sultats post√©s ou publi√©s dans les 12 mois,NCT02244125,,,2023,A Multicenter Open Label Phase II Study of Pomalidomide and Cyclophosphamide and Dexamethasone in Relapse/Refractory Multiple Myeloma Patients Who Were First Treated Within the IFM/DFCI 2009 Trial,PCD,PROCEDURE
‚¨õ,4,4 : pas de r√©sultats post√©s ni publi√©s,NCT04827030,,,2023,A Double-blind Randomized Non-inferiority Trial of Erector Spinae Block (ESP) Versus Paravertebral Block (PVB) Before Breast Cancer Surgery: Effects on Acute Postoperative Pain.,ER-One,DRUG
‚¨õ,4,4 : pas de r√©sultats post√©s ni publi√©s,NCT02864563,,,2023,Pan-genome Analysis of Neuroblastoma by Comparative Genomic Hybridization and Correlation With Pathology for the Diagnostic and the Prognostic Classification,PHRCNB07,PROCEDURE
‚¨õ,4,4 : pas de r√©sultats post√©s ni publi√©s,NCT04217109,,,2023,KDOG1 :Transcutaneous Breast Cancer Diagnosis by Canine Odorology,KDOG1,DIAGNOSTIC_TEST
‚¨õ,4,4 : pas de r√©sultats post√©s ni publi√©s,NCT04634097,,,2024,DECLIC Patient Education Program : Assessment Through a Population Health Intervention Research Approach (LE DECLIC EPRI),,OTHER
üü©,1,1 : r√©sultats post√©s ou publi√©s dans les 12 mois,NCT02866149,,,2024,Analysis of Circulating Tumor Markers in the Blood,ALCINA,PROCEDURE
‚¨õ,4,4 : pas de r√©sultats post√©s ni publi√©s,NCT02802969,,,2024,"Improvement of Local Control in Skull Base, Spine and Sacral Chordomas Treated by Surgery and Protontherapy Targeting Hypoxic Cells Revealed by [18F]FAZA) PET/CT Tracers",PROTONCHORDE01,PROCEDURE
‚¨õ,4,4 : pas de r√©sultats post√©s ni publi√©s,NCT04402606,,,2024,DERMACLIC : Study on Skin Toxicities Induced by Cancer Treatments,DERMACLIC,OTHER
‚¨õ,4,4 : pas de r√©sultats post√©s ni publi√©s,NCT05141383,,,2024,Comparative Study of Diagnostic and Prognosis Biomarkers of Prostate Cancer in Liquid Biopsy,HOPE,OTHER
‚¨õ,4,4 : pas de r√©sultats post√©s ni publi√©s,NCT04728113,,,2025,Early Integration of Supportive Care Into Standard Oncology Care for Metastatic Uveal Melanoma Patients,,OTHER
‚¨õ,4,4 : pas de r√©sultats post√©s ni publi√©s,NCT05011721,,,2025,"Digital Phenotyping (Physical Activity, Heart Rate, Sleep) in Young Breast Cancer Patients Treated With Neoadjuvant Chemotherapy",NeoFit,DEVICE
‚¨õ,4,4 : pas de r√©sultats post√©s ni publi√©s,NCT01868269,,,2025,Multinational European Trial for Children With the Opsoclonus Myoclonus Syndrome / Dancing Eye Syndrome,,DRUG
‚¨õ,4,4 : pas de r√©sultats post√©s ni publi√©s,NCT04934865,,,2025,Real Life Prospective Multicentric Study Evaluating the Clinical and Organisational Impact of Moovcare¬Æ Lung Connected Medical Device in Lung Cancer Patients : REAL-MOOV-LUNG,REAL-MOOV-LUNG,DEVICE
‚¨õ,4,4 : pas de r√©sultats post√©s ni publi√©s,NCT00792025,,,,A Multicentre Phase II Trial to Determine the Efficacy of the Anti-Tyrosine Kinase Sunitinib (Sutent¬Æ) as Second Line Therapy in Patients With Transitional Cell Carcinoma (TCC) of the Urothelium Which Failed or Progressed After First Line Chemotherapy for Advanced or Metastatic Disease,,DRUG
